Cell Culture Protein Surface Coatings Market Is Expected To Reach US$ 1,258.7 Mn By 2025

The latest market report published by Credence Research, Inc. “Global Cell Culture Protein Surface Coatings Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025,” the global cell culture protein surface coatings market was valued at US$ 369.3 Mn in 2016, and is expected to reach US$ 1,258.7 Mn by 2025 expanding at a CAGR of 13.16 % from 2017 to 2025.

Browse the full report Global Cell Culture Protein Surface Coatings Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/cell-culture-protein-surface-coatings-market

Market Insights

Cell culture protein surface coating is necessary to increase the adhesion and proliferation of the cells in in-vitro conditions and their isolation. Usually the inner surface of the petri dish or flask is coated with extracellular matrix or proteins such as laminin, collagen, fibronectin, vitronectin etc.  In 2016, animal derived protein surface coatings dominated the market significantly due to key market drivers such as its suitability for thin layer tissue culture and its high gel concentration is useful in providing stiffness and scaffold integrity during its application in 3D cell culture. The synthetic sources segment will be the fastest growing market throughout the forecast period 2017-2025, as it finds increasing demand for cell cultivation since it is devoid of animal derived components and the minimal risk of contamination during cell culture isolation.

Click Here To Browse Report on Cell Culture Protein Surface Coatings Market: http://www.credenceresearch.com/report/cell-culture-protein-surface-coatings-market

Based on product types, self-coatings segment dominated the cell culture protein surface coatings market due to factors such as its wide application in 2D and 3D cell culture and in the production of pluripotent stem cells and cell culture preservation. Pre-coatings segment will be the fastest growing market throughout the forecast period 2017-2025, due to the intricate features it possess such as less time consumption, ease of use and improved cell cultivation and isolation.

In 2016, North America held the largest revenue share in the global cell culture protein surface coatings chiefly due to factors such as pharmaceutical giants focusing on drug discovery and development, rising demand for personalized medication and growing public awareness regarding health leading to increase in disease diagnosis employing cell culture techniques. Asia Pacific will be the fastest growing market through the forecast period 2017-2025, majorly due to factors such as increasing demand for pharmacogenomics studies for drug safety and efficacy, presence of large patient pool, evolving healthcare infrastructure and growing public-private partnerships to establish research and development centers.

Key Market Movements:

– Rising public awareness regarding health and early disesase diagnosis

– Increasing demand for pharmacogenomics to enhance drug safety and efficacy

– Supportive regulatory environment for cell culture protein surface coating products

– Increasing government funding in R&D centers for drug discovery and development

Latest Reports:

Hospital Acquired Disease Testing Market: http://www.credenceresearch.com/report/hospital-acquired-disease-testing-market

Drug of Abuse Testing / Screening Market: http://www.credenceresearch.com/report/drug-of-abuse-testing-screening-market

About Us: 

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared for this task.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com

Advertisements

Global Glycomics/ Glycobiology Market Size, Share, Growth, Trends, Opportunities and Forecast 2017 To 2025 – Credence Research

According to the latest market report published by Credence Research, Inc. “Glycomics/ Glycobiology Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global glycomics/ glycobiology market was valued at US$ 657.3 Mn in 2016, and is expected to reach US$ 1,891.9 Mn by 2025, expanding at a CAGR of  12.4% from 2017 to 2025.

Browse the full report Glycomics/ Glycobiology Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/glycomics-glycobiology-market

Market Insights

Glycomics/ glycobiology is a study of structure, function and biology of saccharides which are widely distributed in nature. Sugars are important component of all living cells and thus play important role in various medical, biochemical and biotechnological research field. For the purpose of this study, the glycomics market is segmented on the basis of product type such as enzymes (glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, sulfatases, carbohydrate kinases, other enzymes), instruments (antibody arrays, HPLC, lectin arrays, MALDI-TOF, mass spectrometers, other instruments), kits (glycan labeling kits, glycan purification kits, glycan release kits, other kits), reagents (glycoproteins, monosaccharides, oligosaccharides, other reagents). Currently, instruments held the largest market share due to higher costs and its prime role in glycobiology. It is anticipated that enzymes will show the highest growth during forecast period due to increasing use in research and development activities.

Click Here To Download Full Report Sample on Glycomics/ Glycobiology Market : http://www.credenceresearch.com/sample-request/58656

Glycobiology has wide range of applicability; but for the purpose of the study, this market is categorized as diagnostics, drug discovery & development, oncology, immunology other applications.  It is studied that, in the base year 2016, drug discovery & development was major revenue generating segment because increase in R&D activities for the development of novel therapies and higher number of unmet needs are primarily driving the market growth. Glycobiology market is currently dominated by North America due to technological advancement, higher investment in R&D activities and presence of large number of biotechnology, biopharmaceutical industries and research institutes. However, due to increasing government investments in the life sciences sector and increasing partnership of key players with local manufacturer, and rapidly expanding life science industries in this region the market will witness phenomenal growth.

Market Competition Assessment:

The glycomics/ glycobiology market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Agilent Technologies, Bruker Corporation, Danaher Corporation, Merck KGaA, New England Biolabs, Prozyme, Inc., R&D Systems, Inc., Shimadzu Corporation, Takara Bio, Inc., Thermo Fisher Scientific, Waters Corporation and others.

Browse here for full report: http://www.credenceresearch.com/report/glycomics-glycobiology-market

Key Market Movements:

– Factors such as increase in number of biotechnology and biopharmaceutical industries, technological advancement and increasing applicability of glycobiology in drug discovery and development are major factors that driving the growth of glycomics/ glycobiology market globally.

– Increasing demand of personalized medicines for the treatment of several severe chronic diseases would drive the glycomics/ glycobiology market growth during forecast period.

Blog: http://www.technicaltop.com/2017/09/07/glycomics-glycobiology-market-global-industry-size-share-growth-trends-outlook-opportunities-and-forecast-2017-to-2025/

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Global Western Blotting Market Size To Reach Worth US$ 872.5 Mn By 2025

According to the latest report published by Credence Research, Inc. “ Western Blotting Market – Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global western blotting market was valued at US$ 548.9 Mn in 2016, and is expected to reach US$ 872.5 Mn by 2025, expanding at a CAGR of 5.1% from 2017 to 2025.

Browse the full report Western Blotting Market – Growth, Future Prospects and Competitive Analysis, 2017–2025 at http://www.credenceresearch.com/report/western-blotting-market

Market Insights

Western blotting or protein immunoblot is used for quantification and detection of specific proteins based on molecular weight and size. Western blotting contributes significant share in the overall molecular diagnostics market as this technique is used in several analytical processes. Western blotting is also considered as a prime tool for HIV diagnostics due to its high specificity. The growth of global western blotting market is majorly attributed to factors such as growing biotechnology research, growing incidence of HIV/AIDS, and increasing R&D initiatives in the field of pharmaceuticals and biotechnology, and growing need for personalized medicine. Further proliferation of proteomics research and applications is also supporting the high demand for western blotting products.

Based on the product types, the global western blotting market is classified into consumables (reagents and kits), instruments such as blotting systems (wet blotting instruments and semi-dry blotting instruments) and imagers (chemiluminescent imagers, fluorescent imagers and others). Among these, reagents and kits segments account for majority market share and will continue to dominate the market through the forecast period. Additionally, rapid adoption of imager systems will contribute to the fastest growth rate of this segment.

Based on applications, biomedical and biochemical research segment accounted for the largest revenue share in 2016. Rising number of R&D activities held by biotechnology and pharmaceutical companies and growing government funding for such research for rapid commercialization of breakthrough products are the key drivers of this segment. On the other hand, it is expected that disease diagnosis segment will witness the fastest growth during the forecast period. Significant growth in incidence of HIV/AIDS and rising prevalence of infectious diseases such as Hepatitis and Lyme diseases majorly support the growth of this segment.

Browse full report at http://www.credenceresearch.com/report/western-blotting-market

Considering the usage areas, the global western blotting market is studied for research and academia, pharmaceuticals and biotech, disease diagnosis and others. Among these usage areas, pharmaceuticals and biotech is the largest segment in 2016. However, due to growing research and development activities, increasing hoard for rapid commercialization of novel techniques and growing government funding for research initiatives in will make research and academia the fastest progressing usage area segment in the overall western blotting market.

Geographically, North America is the largest revenue generating regional market for western blotting and will continue its dominance through the forecast period. Ample availability of funds for research work, high demand for personalized medicine, and domicile of major market players in the region makes North America the largest regional market for western blotting. On the other hand, rapid outsourcing of research activities, growing skills and awareness, and high incidence of infectious diseases will contribute to the highest growth rate of Asia Pacific market.

Download Free Sample Request: http://www.credenceresearch.com/sample-request/58630

The global western blotting market is highly competitive in nature and is also characterized by the presence of several large and small-sized companies. Some of the major players observed in this market are Advansta, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, F. Hoffmann-La Roche Ltd., GE Healthcare, LI-COR Biosciences, Merck KGaA, PerkinElmer, Inc., Sigma-Aldrich Co., Thermo Fisher Scientific, Inc. and Trinity Biotech plc.

Blog: http://www.technicaltop.com/2017/08/23/western-blotting-market-global-industry-size-share-growth-trends-outlook-opportunities-and-forecast-2017-to-2025/

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Pipeline Monitoring Solutions Market Size, Share, Growth, Outlook, Opportunities and Forecast 2017-2025 : Credence Research

According to a new market report published by Credence Research “Global Pipeline Monitoring Solutions Market – Growth, Future Prospects, Competitive Analysis, and Forecast 2016 – 2024,” the Global Pipeline Monitoring Solutions Market has been estimated to be valued at US$ 7.7 Bn by the end of 2016, and is expected to reach US$ 12.6 Bn by 2024, expanding at a CAGR of 6.4% from 2016 to 2024.

Browse the full Global Pipeline Monitoring Solutions Market – Growth, Future Prospects, Competitive Analysis, and Forecast 2016 – 2024 report at http://www.credenceresearch.com/report/pipeline-monitoring-solutions-market

Market Insights

Global pipeline network is about 3.5 million kilometers used for safe movement of oil & gas product. Pipelines are considered to be the safest and the most efficient mode of transportation of hydrocarbons as the products are hazardous in nature and any spillage or leakage can results in huge loss to the product owner as well as to the environment. Growing demand for fossil fuel coupled with increasing international trade promoting the usage of pipeline infrastructure for the transportation of oil & gas products. Further, recent accident happened in recent past such as explosion in gas pipeline in Minnesota, U.S., and eruption of natural gas pipeline in Nebraska in 2014 has bought in legislation for the pipeline carrying hazardous products to mandatory have pipeline monitoring systems. Thus, global pipeline monitoring system market is anticipated to driven by factors such as increasing demand for fossil fuels, increasing trade of oil & gas products coupled with growing pipeline infrastructure and associated regulatory policies. However, volatile oil prices restricting cash flow of the oil producers which is likely have a negative impact on upcoming pipeline project which in turn is expected to restrain the demand for pipeline monitoring solutions during the forecast period (2016-2024).

Competitive Insights:

Global pipeline monitoring system market is segmented on the basis of technology & solutions, type, vertical, services and geography. By technology & solutions, industrial control systems segment is projected to be the most dominant and fastest growing segment. Increasing use of automation in pipeline operations due to growing proclivity towards the safe and efficient operations is expected to drive the growth of the segment. Considering services, the consulting segment to be the largest segment over the forecast period owing to growing inclination towards data based decision making and extenuation of risk is projected to drive the growth of the segment over the forecast period. On the basis on vertical, natural gas segment was the largest segment in 2015 and projected to register high growth over the forecast period. Increase production of non-conventional shale gas along with conventional natural gas production is expected to fuel the growth of the segment during the forecast period (2016-2024). The key players in the market are focusing on research & development of new technologies to enhance accuracy of their products.

Download Free Sample Request: http://www.credenceresearch.com/sample-request/58365

Overall, global pipeline monitoring solutions market is projected to register significant growth over the forecast period (2016-2024).

Key Trends:

  • Merger & Acquisition
  • Development of new technologies

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Global Biomarkers Market Size, Growth, Outlook, Competitive Strategies and Forecast 2016 to 2022 – Credence Research

Credence Research has recently issued a new market assessment report titled “Biomarkers Market – Growth, Future Prospects and Competitive Analysis, 2016 – 2022”. The global Biomarkers Market study provides a comprehensive view of the ongoing and future phases of the Biomarkers industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution.

Browse the report at http://www.credenceresearch.com/report/biomarkers-market

Based on geographic/regional distribution the global Biomarkers Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Biomarkers Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa markets. Among these, the North America, Europe and Asia-Pacific Biomarkers Market is studied for top country-level markets. The Biomarkers industry in each individual country market is studied based on parameters such as per capita income, population, gross domestic product (GDP), status of infrastructure, purchasing power parity, etc. Technology development, industry concentration, end-user preference, and similar such grounds are also considered while estimating the market for Biomarkers. The market estimates are provided for the period 2014-2022, along with corresponding compounded annual growth rates (CAGRs) for the forecast period 2016-2022.

Request Table of content – http://www.credenceresearch.com/request-table-of-content/57732

This report on Biomarkers Market also offers competition assessment tools such as market positioning of key players, attractive investment proposition, and Porter’s Five Forces model to give the readers a view of the competitive scenario of the Biomarkers Market. The Biomarkers Market report is concluded with company profiles chapter. This section highlights major information about the key players engaged in development, manufacture, distribution and sale of Biomarkers in the international markets.

Major extracts from the Table of Content of Biomarkers Market, 2016-2022 report:

Biomarkers Market Dynamics – Drivers, Challenges, Opportunities

Biomarkers Market Size and Forecast for the Period 2014-2022

Biomarkers Market CAGR for the Period 2016-2022

Biomarkers Market Competitive Analysis, by Key Players

Biomarkers Market: Attractive Investment Proposition, by Geography

Biomarkers Market: Key Commercial Events

Biomarkers Market: Future Prospects (upcoming product approvals)

Company Profiles

Request free sample – http://www.credenceresearch.com/sample-request/57732

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Global Metabolomics Market – Growth, Future Prospects, Competitive Analysis and Forecast 2017 – 2025 : Credence Research

The latest market report published by Credence Research, Inc. “Metabolomics Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025”, the global metabolomics market was valued at US$ 621.1 Mn in 2016, and is expected to reach US$ 2,428.1 Mn by 2025, expanding at a CAGR of 15.3% from 2017 to 2025.

Browse the full report Metabolomics Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/metabolomics-market

Market Insights

Metabolomics is the study of chemical process that involves small molecules known as metabolites, present within cells, tissues, biofluids or organism. Metabolites are specific unique chemicals that are left behind in any cellular process, which can be studied for metabolite profiling. Such metabolites include amino acid, sugar, organic acids and volatile metabolites, secondary metabolites includes such as phenolic compound, alkaloids etc.; and pigments such as anthocyanins, carotenoids etc. Metabolomics study helps in integrating technology and the biological pathway, and understand the interaction between cellular level interactions with environment which would produce metabolome. There is being increase in funding for research in academics, industry and government. It is used in agricultural pharmaceutical and preventive healthcare industries etc. Due to it non-invasive nature of metabolomics and closely linked to phenotype make up.

Metabolomics is the novel dynamic field which is continuously evolving. Along with proteomics, transcriptomics and genomics, it is forming robust integrative framework for further study of drug discovery and development. Though metabolomics is in early budding phase, there is a conjecture that over period of time it would be widely used in biopharma industry for drug development. In coming years, with the help of personalized metabolomics, we will be able track the changes in the metabolome and further help in designing personalized drug and improve the treatment strategies accordingly.

The global metabolomics market is segmented by product and service type as metabolomics instruments and metabolomics bioinformatics tools and services. Metabolomics instruments is sub segmented into separation tools and detection tools. Separation tool includes high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography and capillary electrophoresis. Detection tools includes mass spectrometry, nuclear magnetic resonance spectroscopy and surface-based mass analysis. Metabolomics is sub segmented includes bioinformatics tools & databases and bioinformatics services.  Metabolomics instruments occupies the largest market share of the global metabolomics market.

The global metabolomics market is segmented by application type biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine and others. Biomarker discovery dominates the global metabolomics market by application type. The global metabolomics market is segmented by indication type cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism and others. Cancer dominates the global metabolomics market by indication type.

As of the current market scenario, North America dominates the global metabolomics market due to surge in research and development by government and private funding for metabolomics studies, easy accessibility in technological advancement in the equipment, rising demand for personalized medicine and toxicology testing. Asia Pacific is the fastest growing metabolomics market due to presence of number of pharmaceutical and biotechnology companies and its initiatives in research and development, rise in disposable income and improving health care infrastructure.

Market Competition Assessment:

Key players in the global metabolomics market are

Agilent Technologies, Inc., Acureomics AB, Amatsi Group, Bayer,Inc., Berg LLC, Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker Corporation, Chenomx, Inc, Danaher Corporation, Human Metabolome Technologies, Inc., HepatoChem, Inc., Human Metabolome Technologies, Inc., IROA Technologies, Leco Corporation, Metabolon, Inc., Max Planck Society, Metabolomic Discoveries GmbH, Metabolomx, Metabometrix Ltd., Metanomics GmbH, Phenomenome Discoveries, Inc., SCIEX, Shimadzu Corporation, SiDMAP, Stemina Biomarker Discovery, Inc, Thermo Fisher Scientific, Inc., Waters Corporation, Xceleron, Inc.

Download Free Sample Request : http://www.credenceresearch.com/sample-request/58420

Key Market Movements:

  • With advent of personalized medicine, diseases can be characterized at molecular level and design and develop the drug treatment according to individual. Metabolomics studies help in characterization of disease phenotypes and further identify personal metabolic features that would help in predicting the response to the therapies. Rise in personalized medicine will boast the metabolomics market
  • There is being huge investments by government & pharma companies in the field of research and development of metabolomics. In biopharma R&D, the usage of metabolomics is showing paradigm shift from preclinical space to transforming pharmacology and clinical development
  • Metabolomics is routinely used as tool for biomarker discovery for informs decision making due to its potential advantage in terms of specificity and sensitivity

Blog Url – http://www.mobilecomputingtoday.co.uk/5245/global-metabolomics-market-expected-reach-2428-1-2025-credence-research/

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Global Next Generation Sequencing Market Size, Share, Growth, strategies, Opportunities and Forecast – Credence Research

According to the latest report published by Credence Research, Inc. “Next Generation Sequencing Market – (Technology Type – Whole Genome Sequencing, Targeted Resequencing, RNA Sequencing, Whole Exome Sequencing, and De Novo Sequencing); (Application – Oncology, Genetic Screening, Infectious Diseases, Drug and Biomarker Discovery, Agriculture & Animal Research, Idiopathic Diseases and others): Market Growth, Future Prospects and Competitive Analysis, 2016-2024” the market was valued at USD 2.6 Bn in 2015, and is expected to reach USD 20.6 Bn by 2025, expanding at a CAGR of 21.5% from 2016 to 2025.

Browse the full report Next Generation Sequencing Market: Market Growth, Future Prospects and Competitive Analysis, 2016-2025 report at http://www.credenceresearch.com/report/next-generation-sequencing-market

Market Insights   

Next generation sequencing is a high-throughput sequencing that enables sequencing and assembling of number of short DNA reads at a small period of time and with a better accuracy. The introduction of next generation sequencing technologies has ensured massive changes in the sequencing process by providing better output, higher speed, flexibility and reduced sequencing cost over thousand folds. Technologically, the approaches for any next generation sequencing procedure can be categorized into whole genome sequencing, targeted resequencing, Rna sequencing, whole exome sequencing and de novo sequencing. With the advancement in technology and development of high throughput sequencing platforms such as HiSeq and MiSeq, it has become increasingly efficient to sequence larger number of base pairs in single cycle reads. Targeted resquencing held the largest share in the global next generation sequencing market due to its accuracy, and its rising preferences in the research and development. De novo sequencing is anticipated to grow at the fastest rate during the forecast period due to its faster, more accurate characterization of any species compared to traditional methods.

Next-generation sequencing (NGS) technologies have progressive advantages in terms of cost-effectiveness, unprecedented sequencing speed, high resolution and accuracy in genomic analyses. Technological developments in the next generation sequencing market are expected to enable researchers to generate phase resolved HLA sequences in single read cycles and provide insight into the lesser accessible regions of HLA genes. Furthermore, the development of prenatal genome sequencing for analysis of genetic anomalies and diseases is also expected to witness enhanced demand, thus driving the genetic screening market. Growing incidences of cancer and infectious diseases, and increasing use of next generation sequencing to develop biopharmaceuticals and drugs for their cure are further expected to drive demand for next generation sequencing.

Geographically, North America was observed as the largest revenue generating market for next generation sequencing market, where the U.S. held the largest market share. The major factors driving the market are technological advancements in the field of life sciences, availability of commercial solutions for next generation sequencing data analysis, and presence of key players in the region. Moreover, extended support from the government institution for genomic research for drug discovery and genetic screening is also driving the market for next generation sequencing in North America and Europe. Asia-Pacific is expected to grow at the fastest rate with throughout the forecast period owing to growing medical awareness in the regional population, increasing investment for development of healthcare and rising oncology and infectious disease research in the region.

Market Competition Assessment:

The next generation sequencing market currently possesses numerous companies having their products marketed, however, Illumina, Inc. dominates the market wholly. Most of the companies are located in the North America and others developed regions. The companies have untapped opportunities in the developing regions of Asia Pacific and Latin America. Companies are coming up with various products in the developed nations due to high acceptance and accessibilities of these products. The companies include, ThermoFisher Scientific, Pacific Biosciences of California, F.Hoffman-La Roche AG Qiagen, BGI and Others.

Download Free Sample Request : http://www.credenceresearch.com/sample-request/58405

Key Market Movements:

  • Continuous introduction of new products and high level of accuracy offered by the products have accelerated the demand of next generation sequencers
  • Extended clinical application of the next generation sequencing technologies in the field of various diseases and drug discovery driving the market

Blog Url – http://www.mobilecomputingtoday.co.uk/5184/global-generation-sequencing-market-reach-worth-usd-20-6-2025-credence-research/

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Global Starter Culture Market Size, Share, Growth and Forecast to 2024 – Credence Research

The latest market report published by Credence Research, Inc. “Global Starter Culture Market– Growth, Future Prospects and Competitive Analysis,2016 – 2024” the starter culture market was valued at USD814.4Mn by value and 1,107.5 kilo ton by volume in 2015, and is expected to reach USD1,426.9 Mn by value and 1,896.1 kilo ton by volume by 2024, expanding at a CAGR of 6.1% by value and 5.8% by volume from 2016 to 2024.

Browse the full report Global Starter Culture Market- Growth, Future Prospects and Competitive Analysis, 2016 – 2024report at http://www.credenceresearch.com/report/starter-culture-market

Market Insights

Starter culture is consortium of microorganism and due to its significant metabolic activities; these are used to initiate fermentation process. Starter culture is the key ingredient of various fermentation industries. The starter culture market is anticipated to grow in the forecast period, due to increase in use of fermented food and beverages, with rampant consumption of alcoholic globally. Starter culture market is segmented on the basis of type of microorganism use such as lactic starter culture and non lactic starter culture. Lactic starter culture further segmented as Cocci and Rods. Non lactic starter culture further segmented as Bacteria (Except Rods and Cocci), Molds and Yeast. Lactic acid bacterial starters generally used by dairy industries and non lactic acid bacteria plays important role in baked products and beverage preparing industries. Global starter culture market also segmented on the basis of strain used to initiate fermentation process. Single strain fermentation cultures are extensively used in dairy industries however the major problem associated with single strain starter culture is there will be sudden failure of starter due to bacteriophage attack which leads to heavy loss to the industry. While mix strain contain more than two strain in together, due to its consistency and predictability widely used in the milk industry and especially in the preparation of cheese. According to micro-organisms growth temperature global starter culture market segmented as Mesophilic starter culture and thermophilic starter culture. Mesophilic starter cultures are primarily preferred for American-style and specialty cheeses while thermophilc starter cultures are frequently used in Italian-style cheeses. Mesophilic starter cultures held the largest share in the global starter culture market by organism growth temperature. Global starter culture market also segmented on the basis of application of starters such as Alcoholic and Non-alcoholic product. Alcoholic starter culture market is largest in Europe. Non-alcoholic starters plays important role in cheese, baked and dairy products manufacturing. These are also used in preparation of probiotics and fermented health drinks. Due to the change in consumption pattern globally demand for fermented food increased extensively in last two decades and thus global market for Non-alcoholic starter is comparatively large.

Europe was observed as the largest market for starter culture as the highest demand for alcoholic beverage in this region, increased use of probiotics and willingness of consumers to pay premium prices for beverages -with health benefits would further drive the market growth in this region. North America accounted for the second largest market for starter culture. The market is driven by tremendous technological advancement, the substantial increase in the demand for alcoholic and fermented nutritional product in the region. In Asia Pacific market, due to its immense population and robust growth rate, culture, and market dynamics, it will continue to grow as a global trendsetter of starter culture market.

Market Competition Assessment:

The Starter culture market is observed as the most competitive and comprises of large number of players. However, the market is dominated by fewplayers such asChr. Hansen A/S, Danisco A/S, and Lasaffre group. Other key players in this market are C.S.K. Food enrichment B.V., D.S.M. Food Specialities, Biena, Lallemand Inc., Wyeast laboratories and others.

Request Free Sample : http://www.credenceresearch.com/sample-request/58337

Key Market Movements:

  • Change in Consumers dietary pattern, rising demand for fermented, baked and dairy based products key growth driver for the market.
  • Increased consumer awareness for preventive and better healthcare, increased use of probiotic drinks, discovery of novel probiotics, would further drive the market during forecast period.
  • The market is driven by the substantial increase in the demand for alcoholic products also some region has seen tremendous technological advancement in the process of fermentation.
  • Discovery of novel probiotics and fermented diary beverages entering the market, will boast the demand of the nutritious fermented product.
  • As the starter culture does not have specific definitions due to its varied application, so it is difficult to assess uncertainties are associated with it.
  • Introduction of novel probiotics and fermented diary beverages entering the market will further increase the demand of the fermented product.

Latest Report:

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Global Digital Pcr Market Size, Share, Growth, Strategies, Analysis, Opportunities and Forecast to 2023 – Credence Research

The latest market report published by Credence Research, Inc. “Global Digital PCR Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2023” the digital PCR market was valued at USD 196.7 Mn in 2015, and is expected to reach USD 749.4 Mn by 2024, expanding at a CAGR of 18.2% from 2016 to 2023.

Browse the full report Digital PCR Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2023 report at http://www.credenceresearch.com/report/digital-pcr-market

Market Insights

Digital PCR (dPCR) plays key role in precise quantification of nucleic acids. Similar assay reagents are used in dPCR which are also used in standard analog measurements, but counts the total number of individual target molecules in a digital format. This enables many applications that require high sensitivity and have restricted sample availability. The market experts suggested that there is growing interest in digital PCR (dPCR) because technological progress has made it a practical and increasingly affordable technology. The unique sample partitioning step of digital PCR, paired with Poisson statistical data analysis, allows higher precision than traditional PCR and qPCR methods. On the basis of components and services the dPCR market can be segmented as dPCR instrument, reagents and consumables, and dPCR software and services. In 2015 it was observed that dPCR reagents and consumable segment was the largest segment and accounted for the market share. The several applications of dPCR comprises of clinical applications, research applications, and forensic applications. It was observed that research applications was largest segment in overall applications market due to high demand of dPCR in drug discovery and growing R&D in oncology research.

North America is observed to be the largest regional market for dPCR, followed by Europe. The dominance of North America in the dPCR market is attributed to factors such as evolved healthcare infrastructure, early bird market entry of novel healthcare products and solutions in the U.S. market, high private and public funding in healthcare and life sciences research. However, Asia Pacific is anticipated to be the fastest progressing regional market for dPCR technologies. Chief factor attributed to the progress of Asia Pacific market include rapid entry of global market giants in the region, development of healthcare infrastructure, escalated status of Asia as a hub for CRO and CMO activities, and growing cancer and gene research in the region.

Market Competition Assessment:

The Digital PCR market is observed as the most competitive and budding market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., Sigma-Aldrich Corporation, BioRad Laboratories, Fluidigm, and RainDance Technologies.

Request Free Sample : http://www.credenceresearch.com/report/digital-pcr-market

Key Market Movements:

Significant  development in the field of personalized medicine and targeted drug monitoring is increasing the demand of dPCR in research applications

The key challenge faced in digital PCR  market lack of awareness related to the potential of dPCR in developing and underdeveloped countries

The major opportunity in malignant ascites treatment market is shift from plant-derived to genome-based drug discovery is key opportunity in dpcr market

Latest Report:

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact:

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States

Ph: 1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com

Blog at WordPress.com.

Up ↑